The prion protein (PrP) is a Cu 2؉ binding cell surface glycoprotein that can misfold into a ␤-sheet-rich conformation to cause prion diseases. 
coordination utilizing histidine residues. Studies with PrP analogues show that the high affinity site requires both His 96 and His 111 as Cu 2؉ ligands, rather than a complex centered on His 96 as has been previously suggested. Our circular dichroism studies indicate a loss of irregular structure on copper coordination with an increase in ␤-sheet conformation. It has been shown that this unstructured region, between residues 90 and 120, is vital for prion propagation and different strains of prion disease have been linked with copper binding. The role of Cu 2؉ in prion misfolding and disease must now be re-evaluated in the light of these findings.
Prion diseases are fatal neurodegenerative diseases that include Creutzfeldt-Jacob disease in humans, mad cow disease in cattle, and scrapie in sheep. The infectious agent in transmissible spongiform encephalopathies is a proteinous infectious particle or "prion," which is devoid of nucleic acid. It is believed that these spongiform encephalopathies are caused by the accumulation of an abnormally folded isoform of the cellular prion protein (PrP C ). 1 This misfolded protein is rich in ␤-sheet and is designated the scrapie isoform, PrP Sc (1) (2) (3) . Whereas normal physiological function of the prion protein is yet to be determined, the ability of PrP C to bind Cu 2ϩ in vivo and in vitro suggests a role in copper homeostasis (4, 5) . Indeed, elevated copper levels promote endocytosis of PrP C suggesting that PrP could transport copper into the cell (6, 7) . Recent data has shown that PrP C expression increased the binding of copper to the outer plasma cell membrane and increases antioxidant enzyme activities (8) . Furthermore, it is suggested that PrP C plays a protective role by binding Cu 2ϩ in a redox inactive state (9, 10 ). An enzymatic role for copper-PrP is also proposed as it exhibits superoxide dismutase activity (11) (12) (13) (14) .
The cellular prion protein is a cell surface glycoprotein tethered via a glycosylphosphatidylinositol anchor at the C terminus. There are now a number of NMR solution structures of mammalian PrPs in the copper-free form (15) (16) (17) (18) . A crystal structure of PrP C has also been published. The structure is dimeric involving domain swapping between monomeric forms (19) . Structurally, PrP C contains two distinct regions. In the absence of Cu 2ϩ , the N-terminal domain, residues 23-120, is unstructured (17) and has a high degree of main chain flexibility in the absence of copper (20) . In contrast, the C-terminal domain, residues 121-231, is largely ␣-helical (15) . Residues 60 -91 consist of an octapeptide sequence, PHGGGWGQ, which is repeated four times. It is this unstructured region that binds four Cu 2ϩ ions cooperatively (5) . Although binding of a fifth Cu 2ϩ ion to PrP has been noted (4, 21, 22) , as well as Cu 2ϩ coordination to a C-terminal fragment of PrP (23) . The majority of studies have concentrated on characterizing the four copper ions binding to the octarepeat region of PrP. Recent publications on copper binding to the octarepeats include circular dichroism (CD) studies (24) , electron paramagnetic resonance spectroscopy (EPR) studies (25) , and a crystallographic study (26) . Dissociation constants for Cu 2ϩ binding to the octarepeat region have been reported to be between 1 nM and 10 M (21, 24) although others have suggested a much higher affinity with a K d in the femtomolar range (22) .
Studies with transgenic mice have shown that mice expressing a truncated version of PrP with the octarepeat region removed are still susceptible to prion infection (27) . This has meant that a direct link between copper and prion disease was thought to be unlikely. However, recent studies suggest copper can bind to the unstructured domain of PrP outside of the octarepeat region with a femtomolar dissociation constant (22) . Residues His 111 and/or His 96 have been implicated in this binding (22, 28, 29) . Interestingly, the unstructured region between the N-terminal domain and the structured C-terminal domain is considered to be essential for amyloid formation and infectivity in prion disease (30 -33) . Residues in this unstructured region are thought to play a pivotal role in the misfolding of * This work was supported in part by Biochemical and Biophysical Sciences Research Council (BBSRC) Project grants and a University of London Central Research Fund equipment grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
□ S The on-line version of this article (available at http://www.jbc.org) contains supplemental material.
§ Recipient of a C. J. Martin Postdoctoral Fellowship from the National Health and Medical Research Council, Australia.
ʈ Supported by a Senior Fellowship from the BBSRC. ** To whom correspondence should be addressed. Tel.: 44-020-7882-3054; Fax: 44-020-8983-0973; E-mail: j.viles@qmul.ac.uk. 1 The abbreviations used are: PrP C , cellular isoform of prion protein; PrP, prion protein; PrP Sc , scrapie isoform of prion protein; TOCSY, total correlation spectroscopy; NOESY, nuclear Overhauser exchange spectroscopy.
PrP
C into the ␤-sheet-rich conformation (34) . The presence of a high affinity Cu 2ϩ site within the region 90 -126 should have profound implications for the copper loaded structure in this region of PrP C . Cu 2ϩ can convert the cellular prion protein into a protease-resistant species (35) . Copper induced structuring in this region might also explain the different protease resistance profiles of PrP observed with and without the presence of Cu 2ϩ (36) , these protease profiles correspond to similar profiles seen in different strains of prion disease (37) . In addition, a fragment from this unstructured region, PrP-(106 -126), contains a hydrophobic cluster of residues and has been shown to be neurotoxic in both the soluble and fibrillar states (33, 38) . Copper binding to this peptide has been linked with its toxicity (39) .
Metal imbalances are a feature of prion disease (40) and metal binding to the prion protein is altered in human prion disease (41) . Therefore, it has been suggested that a loss of PrP function in copper transport and homeostasis may well be a feature of prion disease. Recent studies have shown that scrapie infection modulates copper content at a cellular level (42) and that copper-catalyzed redox damage of PrP is implicated in prion disease (43, 44) . Elimination of the copper binding octarepeat region has been shown to slow disease progression (27) . Additionally, a recent study shows that disease progression in infected mice is slowed with the use of copper specific chelation therapy (45) . A mutant form of PrP associated with familial prion disease contains nine additional octarepeats and fails to undergo copper-mediated endocytosis (7) . The role of copper in the normal function of PrP, as well as in prion diseases, has been the subject of a number of reviews (46 -50) .
The aim of this study is to characterize the binding of Cu (28) . In addition, the reported affinities for Cu 2ϩ also vary greatly in the literature between the micromolar (4, 21) and femtomolar (22) dissociation constants. PrP-(23-231) with the octarepeat domain deleted, fragments PrP-(91-115) and PrP-(90 -126) and PrP-(91-115) analogues (H96A and H111A) have been used to identify key residues in Cu 2ϩ coordination. We use direct spectroscopic methods including CD, NMR, and EPR to study the folding, affinity, coordination geometry, stoichiometry, and pH dependence of copper binding to the prion protein. (23-231⌬51-90 ) Protein-The coding region of the full-length mouse PrP-(23-231) with a deleted octapeptide region, named PrP(23-231⌬51-90), was cloned into a pET-23 vector to produce a tag-free protein as previously described (11) . The protein was expressed in 2-liter flasks of Escherichia coli BL21(DE3) cells. Cultures were grown at 37°C to an A 600 of 0.7 and the protein expression was induced by the addition of isopropyl-␤-D-thiogalactopyranoside to 1 mM. Bacterial pellets were harvested after 3 h and sonicated in a buffer containing 8 M urea, 200 mM NaCl, and 50 mM Tris, pH 7.6. The resulting solution was cleared of bacterial debris by centrifugation at 15,000 rpm for 15 min. The protein was absorbed to a copper-charged metal affinity column made from chelating Sepharose (Amersham Biosciences). The protein was eluted from the column using imidazole (300 mM). The purity of the protein was checked by polyacrylamide electrophoresis and Coomassie staining. The protein was refolded by successive rounds of dilution in distilled water, concentrated using vivaspin concentrator (Vivascience), and dialyzed with a 12,000 -14,000 molecular weight cut-off dialysis tube at 4°C against water overnight to remove residual urea. The concentration of PrP(23-231⌬51-90) was measured by its absorbance at 280 nm (A 280 nm 1 mg/ml , 1 cm, ϭ 1.758). Peptide Synthesis and Purification-Peptides representing various fragments of PrP were synthesized employing solid phase Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry (A.B.C, Imperial College, London). After removing from the resin and de-protection, the samples were purified using reverse phase high performance liquid chromatography and characterized using mass spectrometry. To mimic the peptides within the full-length prion protein, all peptides were blocked at the N terminus with N-acetyl and ethyl ester at the C terminus. One and two-dimensional 1 H NMR spectroscopy confirmed the amino acid sequence.
EXPERIMENTAL PROCEDURES

Expression and Purification of Recombinant Mouse Prion PrP
Design of Peptides-Peptides synthesized included: human (PrP) sequence, PrP-(91-115), acetyl-QGGGTHSQWNKPSKPKTNMKHM-AGA; PrP-(90 -126), acetyl-GQGGGTHSQWNKPSKPKTNMKHMAG-AAAAGAVVGGLG; PrP(H96A), acetyl-QGGGTASQWNKPSKPKTNM-KHMAGA; PrP(H111A), acetyl-QGGGTHSQWN KPSKPKTNMKAM-AGA; PrP-(58 -91), PrP(4octa), acetyl-GQPHGGGWGQPHGG-GWGQPHGGGWGQPHGGGWGQ.
Titrations-The pH was measured before and after each spectrum was recorded. Unless otherwise noted, all titrations were carried out in the absence of buffers or salts. For all titrations the pH was adjusted using small aliquots of 100 mM NaOH or HCl. The peptide concentrations were determined using extinction coefficients at 280 nm. An extinction coefficient of 5690 M Ϫ1 cm Ϫ1 (multiplied by the number of tryptophan residues) was used for each peptide (51) . The freeze-dried peptides contained 20 -30% moisture by weight. The addition of metal ions (CuCl 2 ⅐2H 2 O) or competing ligands was performed using small aliquots from freshly prepared stock aqueous solutions.
Stability Constants-The absolute affinity (pH independent) of L-His for Cu 2ϩ is 1.5 ⅐ 10 10 M Ϫ1 , the apparent affinity, at pH 7.4 is therefore 2.6 ⅐ 10 8 M Ϫ1 or a dissociation constant of 3.7 nM (as log ␣ ϭ pK a , pH ϭ 9.17-7.4 ϭ 1.77, and log K 1(app) ϭ log K 1 Ϫ log ␣ ϭ 10.2-1.77 ϭ 8.43 or 2.6 ⅐ 10 8 M Ϫ1 ). The glycine dissociation constant at pH 7.5 is ϳ500 nM (52) .
Circular Dichroism (CD)-CD spectra were recorded on an AVIV 202 instrument at 25°C. Typically a cell with a 0.1-cm path length was used for spectra recorded between 185 and 260 nm with sampling points every 0.5 nm. A 1-cm path length cell was used for data between 300 and 800 nm with a 2-nm sampling interval. A minimum of three scans was recorded and the baseline or apospectra were subtracted from each spectrum. Data were smoothed when necessary. Data were processed using Microsoft Excel and the KaleidaGraph spread sheet/graph package. The direct CD measurements (, in mdeg) were converted to molar ellipticity, ⌬⑀ (M Ϫ1 cm Ϫ1 ) using the relationship ⌬⑀ ϭ /33,000 (53) , whereas samples in 100% D 2 O had residual water suppressed with a low power presaturation pulse. For two-dimensional spectra, quadrature detection in the indirect dimension was achieved using the States-TPPI method. Two-dimensional total correlation spectroscopy (TOCSY) spectra were typically acquired with 2048[F2] ϫ 512[F1] complex points, with water suppression achieved using the W5 Watergate sequence. The TOCSY experiment employed a DIPSI2 sequence for isotropic mixing, with a mixing time of 75 ms (54). Nuclear Overhauser exchange spectroscopy (NOESY) spectra (55) were acquired with 2048[F2] ϫ 512[F1] data points, with mixing times of 200, 300, and 500 ms. Prior to Fourier transformation, sine-squared window functions, phase shifted by 90°were applied to both dimensions, the F1 dimension was forward linear predicted to 512 real points and both dimensions zero filled to 2048 real points. Data were processed using XWINNMR (Bruker) software running on a SGI O 2 work station and analyzed using the program XEASY (56) . Proton resonance assignments and sequential connectivities for PrP-(91-115) were obtained using the TOCSY and NOESY data and standard homonuclear techniques (57) . Analysis of spectra of the H96A and H111A mutants allowed unambiguous assignment of histidine resonance.
Electron Paramagnetic Resonance (EPR)-X-band
EPR spectra were acquired on a Bruker Elexsys E500 spectrometer operating at a microwave frequency of 9.38 GHz. The spectra were acquired over a sweep width of 2500 gauss, a microwave power of 0.63 milliwatt, a modulation frequency of 10 gauss, and a temperature of either 20 or 100 K. At least two scans were acquired per sample. The pH of the peptide samples was adjusted prior to freezing, however, the pH values noted are not altered to take into account freezing effects.
RESULTS
Cu 2ϩ Addition Induces ␤-Sheet Conformation
CD spectra of PrP-(91-115) in the UV region are shown in Fig. 1 . In the absence of copper, PrP-(91-115) gives an predominately random coil CD spectrum in agreement with the structure of full-length PrP in this region (17) . Fig. 1 shows that addition of Cu 2ϩ increases the negative chirality centered at ϳ217 nm with a decrease in the negative CD band at 200 nm. An isodichroic point is observed at 207 nm with Cu 2ϩ addition indicating a single mode of binding up to 1 eq of copper. The changes in the CD spectra with Cu 2ϩ additions are more apparent by obtaining the difference spectra shown as an insert. The changes in the CD spectra upon copper coordination indicate an increase in ␤-sheet or extended conformation, accompanied by a loss of irregular structure. A similar titration with Cu 2ϩ and PrP-(90 -126), at pH 7.5, produces identical UV-CD spectra (data not shown). Copper binding to His 111 and His 96 (14 residues apart) are possible candidates as coordinating ligands and would cause the polypeptide chain to fold back on itself, perhaps inducing anti-parallel ␤-sheet in this region, the CD spectra shown in Fig. 1 
pH Dependence of Cu 2ϩ Binding
Using visible absorption bands and associated CD bands we have monitored the pH dependence of Cu 2ϩ binding to the prion protein fragment, PrP-(91-115). PrP-(91-115) was loaded with 1 mol eq of Cu 2ϩ and the visible absorption spectrum were acquired at a number of pH values between pH 5.5 and 9.4. Fig. 2 , panel A, shows the resulting overlaid spectra. At pH 5.5, a single absorption band is apparent at 610 nm corresponding to Cu 2ϩ d-d electronic transitions. As the pH increases the absorption increases in intensity until ϳpH 9. Above pH 6.5 there is a shift in the absorption maximum from 610 to 540 nm, suggesting a change in the coordination environment of the Cu 2ϩ ion. The absorption maximum and extinction coefficient (between 40 and 100 M Ϫ1 cm
Ϫ1
) for the Cu-PrP-(91-115) complex are typical for a type II Cu 2ϩ complex. The absorption maximum can be sensitive to ligand type. For example, using model peptide complexes of type II copper complexes the wavelength maximum decreases from 765 nm for Cu 2ϩ with a single nitrogen ligand (and three water oxygens) to 540 nm for Cu 2ϩ with four nitrogen ligands (58). The visible absorption spectra observed here are characteristic of three or four nitrogen coordinations in a type II squareplanar arrangement.
Circular dichroism spectra of Cu 1 PrP-(91-115) (1 mol eq of Cu 2ϩ loaded) have been obtained at pH 6.2, 7.2, and 9.2, shown in Fig. 2B . These data show that the arrangement of ligands coordinating the Cu 2ϩ ions changes significantly with pH. The CD spectrum at pH 6.2 gives a maximum CD band at 520 nm and no ellipticity at 580 nm. In direct contrast, at pH 9.2 a maximal negative CD band at 580 nm is observed with negative ellipticity at 520 nm. The spectrum at pH 7.2 is a mixture of the CD spectra from the mildly acidic and basic conditions. A weighted average of the pH 6.2 and 9.2 spectra shows good agreement with the pH 7.5 spectra using a 70:30% ratio of pH 6.2 and 9.2, respectively. Addition of 2 eq of Cu 2ϩ shows further changes in the spectra at all three pH values as shown in The spectra show an increase in the negative ellipticity (⌬⑀) at 217 nm. The inset shows the difference spectra after subtraction of the apo-PrP-(91-115) spectra.
FIG. 2. pH dependence of Cu 2؉ binding to PrP-(91-115).
Panel A, UV-visible spectra of 0.63 mM PrP-(91-115) with 1 mol eq of Cu 2ϩ as the pH was incremented from pH 5.5 to 9.4. Panels B and C, effect of pH on PrP-(91-115) as monitored by CD with 1 and 2 eq of Cu 2ϩ added, respectively. Spectra were acquired with ϳ0.3 mM peptide at pH 6.2, 7.2, and 9.2. chiral C␣, this implies main chain coordination via the carbonyl or amide (59) . The change in coordination geometry and ligands as the pH is raised above the pK a of histidine is likely to be because of the additional coordination of main chain amides as the pH is raised (60) .
Cu 2ϩ Stoichiometry
To determine the copper binding stoichiometry of PrP-(91-115), increasing amounts of Cu 2ϩ were added to each peptide and the visible electronic absorption and accompanying CD bands were monitored. The absorption spectra of Cu 2ϩ binding to PrP-(91-115) at pH 9.2 is shown in Fig. 3 . The absorption band at 540 nm increases until 2 eq of Cu 2ϩ have been added. Beyond 2 eq the spectra display a red shift of the 540 nm peak (to 560 nm at 3 eq) and a significant increase in intensity of the charge transfer band observed below 400 nm.
The Fig. 3 , inset, shows the mole equivalents of Cu 2ϩ added as a function of the absorbance intensity at pH 9.2, 7.5, and 6.0. At pH 7.5 there is a discontinuity in the binding curve at 1 mol eq of Cu 2ϩ indicating that the Cu 2ϩ ions load onto PrP sequentially. The discontinuity at 1 eq of Cu 2ϩ also indicates that there is a significant difference in the affinity between the loading of the first and second Cu 2ϩ ion. There is a second discontinuity in the binding curve at 2 eq of Cu 2ϩ , this is also observed at pH 9.2 where the absorption peak plateaus at two Cu 2ϩ ions. In contrast, at pH 6.2 the absorption saturates soon after 1 mol eq of Cu 2ϩ is added. The titrations described above were also carried out using circular dichroism at pH 6.3 and 9.2 and the CD spectra were acquired between 300 and 800 nm. Fig. 4 , panel A, shows the pH 9.2 titration, whereas panel B shows binding curves at various specific wavelengths. Likewise, the CD spectra at pH 6.3 are shown in Fig. 4 , panel C, and the accompanying binding curves in panel D. The binding curves at pH 9.2 (Fig. 4B) show that the CD bands at 322 and 490 nm have abrupt discontinuities after 1 mol eq of Cu 2ϩ is added. After 1 eq of Cu 2ϩ there is a shift in the isodichroic point at 620 nm. In agreement with the visible absorption spectra at pH 7.5 ( Fig. 3, inset) result in further increases in absorbance and CD bands. These bands are not because of free Cu 2ϩ ions in solution, as copper free in solution is CD silent and gives a absorption band maximum at ϳ800 nm, which is not observed. In an attempt to differentiate weak Cu 2ϩ binding to PrP-(91-115) from the higher affinity Cu 2ϩ binding sites, the prion fragment has been studied (at pH 7.4) in the presence of competing imidazole. Imidazole is a non-chiral molecule and copper-imidazole does not give a CD signal in the visible region (data not shown). In the presence of excess (10 mM) imidazole the CD spectrum of PrP-(91-115) with 4 eq of Cu 2ϩ , pH 7.4, looks very similar to the CD spectra of PrP after only 1 eq of copper is added (see Supplementary Materials). This suggests that at pH 7.4 only one copper ion binds to PrP with a significantly higher affinity than imidazole, as even after 4 eq of Cu 2ϩ are added in the presence of excess imidazole the spectra appear similar to a single copper bound to PrP-(91-115).
Copper Affinity: Glycine and L-Histidine Competition
The affinity of Cu 2ϩ binding to PrP-(91-115) is key to its physiological significance. To investigate the affinity of Cu 2ϩ binding to PrP-(91-115) we have used glycine as a copper competitor. Two glycine molecules can bind to one Cu 2ϩ with K a of 1.2 ⅐ 10 8 via both the amino and carboxylate groups (52). The resulting Cu(Gly) 2 visible absorption bands are CD silent. Fig. 5, panel A, shows the visible region CD spectra for PrP-(91-115) at pH 9.2 as the peptide is titrated to 2 mol eq of Cu 2ϩ . A similar competition experiment was also carried out at pH 7.5. The spectra exhibit a number of bands because of d-d electronic absorptions, with major peaks at ϳ580 and ϳ688 nm. If glycine was able to successfully compete with PrP-(91-115) for Cu 2ϩ ions, then 4 mol eq of glycine would be sufficient to remove both Cu 2ϩ ions from the peptide. Fig. 5 , panel A, clearly shows that even at double the required amount of glycine only a single copper has been abstracted. Similarly, at pH 7.5 after 8 mol eq of glycine (relative to peptide) has been added, only a single copper has been abstracted from Cu 2 PrP-(91-115). Furthermore, only approximately half of a mole equivalent of copper has been removed from the weaker affinity copper site with 4 eq of glycine. This implies that the low affinity site has a K a comparable with, but not less than, that of glycine. With 12 mol eq of glycine the CD band at 480 nm gives the same intensity as is observed with 1 mol eq of Cu 2ϩ . It appears that the higher affinity site binds to copper at least an order of magnitude higher in affinity than the Cu 2ϩ -glycine complex. In a similar study, free L-histidine was used to compete for Cu 2ϩ ions. Fig. 5, panel B , shows the effect of adding increasing amounts of L-His to Cu 2 PrP-(91-115) at pH 9.2. Histidine has a K d for Cu 2ϩ of 0.1 nm at pH 9.2 and 3 nM at pH 7.4 (52). Unlike Cu(Gly) 2 , Cu(His) 2 is not CD silent and gives a positive CD band at 700 nm, shown in Fig. 5B . The weaker binding, second equivalent of Cu 2ϩ , is easily removed from PrP causing a reduction in the negative band at 580 nm and an increase in the positive Cu(His) 2 CD signal at 700 nm. However, even after twice the required amount of L-His has been added to bind all of the Cu 2ϩ present (8 mol eq relative to PrP-(91-115)) the high affinity site remains largely unaffected. This is apparent from the inset in Fig. 5, panel B. The inset compares the CD spectrum of Cu 2 PrP-(91-115) in the presence of 4 eq of L-His with a spectrum that is a linear combination of Cu 1 PrP-(91-115) and Cu(His) 2 , the spectra are almost identical. A histidine competition experiment carried out at pH 7.4 has a similar effect. One and 2 mol eq of histidine relative to Cu 2ϩ does not significantly perturb the Cu 1 PrP-(91-115) CD bands at 480 and 580 nm.
Only after 8 mol eq of L-His relative to Cu 2ϩ do the CD spectra resemble Cu(His) 2 .
From these competition studies it is clear that PrP-(91-115) will bind more than 1 eq of Cu 2ϩ . The second mole equivalent of Cu 2ϩ will bind to PrP with an affinity comparable with glycine, whereas the first, higher affinity binding site will compete successfully for Cu 2ϩ in the presence of glycine or even L-His. A single Cu 2ϩ ion, at pH 7.4, binds to PrP-(91-115) with an affinity slightly greater than to histidine, indicating a nanomolar dissociation constant for the Cu 1 PrP-(91-115) complex.
Competition Studies with PrP(4octa)
There has been much interest in copper binding to the octarepeat region of PrP. We have therefore studied the competitive effect of the octarepeat domain (residues 58 -91) on Cu of approximately Cu 1.5 PrP-(91-115) superimposed on a spectrum of Cu 1.5 -PrP(4octa). We have recently shown that glycine will compete for Cu 2ϩ ions bound to PrP(4octa) (24) . This is in agreement with this study, which shows that two copper ions bind to PrP-(91-115) with a comparable or a greater affinity than glycine. Fig. 6 gives clear evidence that a single Cu 2ϩ ion will preferentially bind to PrP-(91-115) rather than the octarepeat region
Cu 2ϩ Binding to Full-length PrP Indicates PrP-(91-115) Is a Good Model for Binding to Full-length PrP
So far we have presented pH dependence and glycine competition data for the PrP fragment, residues 91-115. In Fig. 7 we present data for PrP(23-231⌬51-90). Full-length PrP-(23-231) is sparingly soluble at pH 6 and above, however, a construct in which the octarepeats have been removed improves the solubility of the protein between pH 6 and 7.7. This construct contains residues 90 -231 necessary for prion propagation with additional N-terminal residues 23-50.
Visible CD spectra shown in Fig. 7 indicate that PrP-(91-115) is a good model for Cu 2ϩ binding to full-length PrP. Fig. 7A shows pH dependence of 2 mol eq of copper binding to PrP(23-231⌬51-90). The visible CD spectra show a close resemblance to Cu 2 PrP-(91-115) over the pH range 6.6 -7.7. A strong negative band is observed at 600 nm, pH 6.6, which becomes more negative and shifts to 620 nm, pH 7.7. The same band is observed for Cu 2 PrP-(91-115) with a similar wavelength and intensity of the CD band. We note there is some variability in the CD bands for Cu 2 PrP-(91-115) between 700 and 800 nm, because of baseline instability, but the d-d band at 580 -600 nm is very consistent between peptide samples and PrP(23-231⌬51-90). Finally, in Fig. 7C we show, as with PrP-(91-115), the 4octa repeat fragment, PrP-(58 -91), does not remove Cu 2ϩ from the high affinity Cu 2ϩ binding site at pH 7.5. Fig. 7C indicates a single Cu 2ϩ will preferentially bind to the region between residues 91 and 115, rather than the octarepeats of PrP. The PrP-(91-115) fragment behaves in an identical fashion to PrP(23-231⌬51-90).
It is clear from this data presented in Fig. 7 that the PrP-(91-115) fragment represents a valid model for copper binding to full-length PrP at physiological pH values. Copper-free fulllength PrP is unstructured between residues 23 and 126, and as a consequence the small PrP fragment is a good model for Cu 2ϩ binding. Visible CD is very sensitive to coordination geometry around the copper ion, however, despite this the spectra of PrP(23-231⌬51-90) show good agreement with Cu 1 PrP-(91-115) spectra. In addition, as would be expected, the competition experiments show that the PrP-(91-115) has the same affinity for Cu 2ϩ as PrP(23-231⌬51-90).
Coordinating Ligands
EPR-X-band EPR was used to investigate the nature of the groups coordinating the copper ion. EPR spectra of PrP-(91-115) at pH 6.5, 7.5, and 9.3 with 1 and 2 mol eq of Cu 2ϩ are shown in Fig. 8, A 23-231⌬51-90) , effect of pH, glycine, and PrP(4octa) competition. Panel A, Cu(II) was added to PrP(23-231⌬51-90) (0.07 mM) to a stoichiometry of ϳ2 at an initial pH of 5.4 and the resulting CD spectrum acquired over the 300 -800 nm range. The pH was incrementally increased and the CD spectrum was obtained at each pH step. Panel B, 1 and ϳ2 (1.8) eq of Cu(II) were added to PrP(23-231⌬51-91) (0.07 mM, pH 7.6) and the CD spectrum was acquired at each addition. Increasing amounts of glycine were added, up to 13.6 mol eq relative to peptide concentration (ϳ8 times Cu(II) concentration) of glycine had been titrated in (dot-dash lines). Panel C, 1 and 2 eq of Cu(II) were added to PrP(23-231⌬51-91) (0.07 mM, pH 7.5) and the CD spectrum was acquired at each addition. A stoichiometric amount of PrP(4octa) (for Cu(II)) was added to Cu 2 -PrP(23-231⌬51-91) and the resultant spectrum was obtained (dashed line), then double the stoichiometric amount was added and the CD spectrum was acquired (dotted line). -(91-115) , effect of pH. Panel A, 0.13 mM copper-PrP-(91-115) with 1 mol eq of Cu 2ϩ at pH 6.5, 7.5, and 9.3. Panel B, 0.13 mM PrP-(91-115) at pH 7.5 and 9.3 with 2 mol eq of Cu 2ϩ , spectra were recorded at 20 K.
FIG. 8. EPR spectra of Cu-PrP
coordinating atoms. At 1 eq of Cu 2ϩ at pH 6.5, a single set of hyperfine splittings are observed with A ͉͉ and g ͉͉ values of 15.3 millikaisers and 2.27, respectively. From a Peisach-Blumberg plot (not shown) the EPR spectra are most typical of equatorial coordination of three nitrogen atoms and one oxygen (3N1O) or two nitrogen and two oxygen atoms (2N2O). As the pH is raised a second set of signals are observed. At physiological pH these signals are quite weak, but when the pH is raised to 9.3 the second set of signals have comparable intensity. The A ͉͉ and g ͉͉ values observed at higher pH values are 17.0 millikaisers and 2.22. These values fall slightly below the nitrogen/oxygen type II values normally observed implying some distortion in the geometry, but are closest to 3N1O or 4N coordination. Similar behavior to the 1 eq spectra is observed when a second mole equivalent of Cu 2ϩ is added, an overlapping set of signals with comparable A ͉͉ and g ͉͉ values and similar pH dependence are observed. This supports the visible absorption spectrum that shows a pH dependence shift in maximum from 610 to 540 nm typical of a change from 3N1O to 4N coordination.
Analysis of the EPR data for PrP-(91-115) over a range of pH values shows that the peptide binds copper in a Type II coordination geometry, containing N and O ligands. The EPR spectra presented here for PrP-(91-115) gives g ͉͉ values of Ͼ2.2, which excludes the involvement of sulfur. Based on the observed A ͉͉ and g ͉͉ values, the possibility of equatorial coordination via a sulfur ligation from (for example) Met 112 is unlikely. Temperature dependence of the EPR spectra was investigated to determine whether there is electron coupling between the Cu 2ϩ ions. The overall appearance and line shape of the spectra is relatively unaffected by raising the temperature from 20 to 100 K (data not shown). The lack of temperature dependence in the spectra indicates that histidine bridging between two copper ions, as is seen in Cu 2 superoxide dismutase complex, is unlikely (62) .
1 H NMR-The effects of Cu 2ϩ on the 1 H NMR spectrum of PrP-(91-115) peptides were studied to determine the nature of the copper binding site. TOCSY and NOESY were used to fully assign proton resonances in the apo-PrP-(91-115) spectrum at pH values ranging from pH 6.5 to 9.3 (see Supplementary Materials for 1 H NMR assignments). Fig. 9 shows that at 0.2 mol eq of Cu 2ϩ , pH 7. In an attempt to further identify the residues involved in Cu 2ϩ binding to PrP-(91-115), two mutants were synthesized with His 96 and His 111 replaced with an alanine residue. Fig. 10 , panels A and B, shows the CD spectra in the visible region of PrP(H111A) and PrP(H96A), respectively. Spectra are shown with 1 mol eq of Cu 2ϩ added. Both PrP(H96A) and PrP(H111A) give spectra very different from that observed for the wild type fragment after 1 eq of copper, pH 7.6. Weighted combinations of the visible CD spectra for PrP(H96A) and PrP(H111A) also bear no similarity to that PrP-(91-115) spectra. We also note that that position and sign of the visible CD bands for the two analogues are pH independent between pH 7 and 9; unlike the spectra of PrP-(91-115) as shown in Fig. 2 , this data is clear evidence that the first, high affinity copper site requires the presence of both His 96 and His 111 residues to form a complex. To gauge the affinity of copper for the two analogues, free glycine was added at pH 7.6. The peptide containing His PrP(H111A) (67%), indicating that Cu 2ϩ binds with a comparable affinity to that of glycine. The glycine competition experiments indicate that both PrP(H111A) and PrP(H96A) have an affinity for Cu 2ϩ considerably less than PrP-(91-115) (2 to 3 orders of magnitude less) supporting our assertion that Cu 2ϩ requires both His 96 and His 111 residues to form a complex. We note that the visible CD spectra for PrP(H96A) and PrP(H111A) are almost mirror images of each other. Visible absorption bands for both analogues are centered at 580 nm with the sign of the CD bands inverted. The hexadecant rule can be used to interpret CD bands in terms of coordination geometry around the metal center (59) . The sign of the CD band indicates the position of the side chain relative to the Cu 2ϩ coordination plane, and from this it is clear that the position of the ligands are inverted. This possibly reflects amide coordination to the residues N terminus of His 96 and to the C terminus of His 111 . The CD of Cu 1 PrP(H111A) is almost identical to spectra of a model peptide Cu 1 GGGH (N-terminal acetylated) recently reported (63) . This supports our assertion that binding of copper to PrP(H111A) is via the imidazole ring of His 96 and main chain amide nitrogen to the N terminus of His 96 . In summary, we have presented compelling evidence that the higher affinity site is a complex that requires both His 111 and His 96 . These observations are summarized in Fig. 11 .
DISCUSSION
It is now generally accepted that under physiological conditions each of the four histidine-containing octarepeats binds a single Cu 2ϩ ion (24, 25) . In addition, another copper ion has been suggested to bind to a so-called "fifth site" on PrP (4, 21, 64) . His 96 and/or His 111 have been implicated in copper coordination (22, 28, 29) . We have shown that PrP(23-231⌬51-90) and PrP-(91-115) bind a single Cu 2ϩ ion more tightly than the octarepeat region. Competition studies indicate that residues between 91 and 115 can remove copper from the four-octarepeat peptide. A second mole equivalent of copper binds to PrP-(91-115) with a comparable affinity to the octarepeats.
The solubility of full-length PrP at pH values where Cu 2ϩ can bind is low, making spectroscopic studies of full-length PrP difficult. A construct in which residues 51-90 have been deleted from PrP-(23-231) has improved solubility. It is clear that between pH 6.6 and 7.7, PrP(23-231⌬51-90) binds to Cu 2ϩ in an identical manner to the fragment PrP-(91-115). High affinity Cu 2ϩ binding to PrP outside of the octarepeat region explains why it is possible to purify PrP(23-231⌬51-90) using a copper affinity column. We have previously reported Cu 2ϩ -bound visible CD spectra for full-length PrP (5). The spectra were obtained with excess Cu 2ϩ (25 mol eq) and as a consequence the spectra are dominated by signals from the octarepeats and signals from the high affinity site only were not apparent. EPR studies of copper-bound full-length PrP support the observation that copper binds to the PrP-(91-115) fragment in an identical fashion to the full-length protein (29) .
Copper binding in the 91-115 region has been suggested to have a femtomolar affinity (22) . Our work suggests a more modest nanomolar dissociation constant, although this is considerably higher than the micromolar dissociation constant suggested by Kramer et al. (4, 21) . The concentration of extracellular Cu 2ϩ is typically 10 M in blood plasma (65) . It is known that a fraction of extracellular Cu 2ϩ will bind to L-His in blood plasma (66) . From these experiments it is clear that PrP has a higher affinity than L-His for Cu 2ϩ . It is therefore initially possible that extracellular PrP will bind Cu 2ϩ under physiological conditions. The affinity of PrP for copper supports the in vivo studies showing that PrP binds extracellular Cu 2ϩ (4) . Based on very strong evidence from our visible CD spectra of PrP(H96A) and PrP(H111A) analogues (Fig. 10) (29) , PrP-(91-115) visible CD spectra would have the same appearance at our analogue PrP(H111A), which gives a very characteristic CD spectra for coordination via the imidazole ring and three preceding amide nitrogens. Furthermore, the affinity of Cu 2ϩ for PrP(23-231⌬51-90) and PrP-(91-115) for Cu 2ϩ are 2 orders of magnitude higher than would be expected for a single imidazole ring and amide main chain coordination. We presume that the EPR study (29) missed this fundamental difference in the complex because after removal of His 111 a square-planar N/O complex was still formed, although with very different coordination ligands. In this situation, visible CD spectra are much more sensitive to a change in ligands.
In addition to the EPR study of the so-called fifth Cu 2ϩ binding site, EXAFS has been used to study copper-PrP-(90 -231) (28) . EXAFS is a very powerful technique for determining ligand distance from a metal center. However, it is incapable of distinguishing square-planar from tetrahedral coordination and in addition, the scattering difference between N and O ligands is slight. For these reasons, without supporting data, EXAFS can at best only suggest the type of coordination. In addition the EXAFS data were obtained at physiological pH, a pH at which we have shown that more than one coordination species is present. This mixture of species will compromise fitting EXAFS data. Taking on board these caveats, the EXAFS study supports our observations that copper coordinates to both His 111 and His 96 (28) . In addition, each HGGGW Cu 2ϩ binding motif in the octarepeat region was similarly modeled using the crystal structure as a guide (26) . The structured region PrP-(121-231) is from James et al. (16) . Protein Data Bank accession code is 1B1O.
The EXAFS study of PrP-(90 -231) (28) suggests nitrogen and oxygen ligands at 1.98 Å. Further out at 3.1 Å, the presence of a sulfur atom improved the EXAFS fit, implicating the involvement of Met 112 in coordination. Our 1 H NMR data indicates a paramagnetic broadening of the resonance corresponding to the Met 112 ⑀-CH 3 group on addition of Cu 2ϩ . The sulfur atom may be close to the copper center (Ͻ7 Å) but any direct coordination to the copper must be an axial, long range interaction, on the basis of our EPR data. Indeed, weakly bound distant ligands axial to the coordination plane generally play only a minor role in magnetic and optical properties of Cu 2ϩ complexes (61) . We note that His 96 and His 111 are conserved in all mammalian species, whereas Met 112 is not (67) . The scattering at 3.1 Å assigned to a Met sulfur ligand is not completely ruled out by our study, but at 3.1 Å from the Cu 2ϩ ion it cannot be a key coordinating ligand. Reliable fitting of attenuated EXAFS signal at Ͼ3 Å is difficult, in addition the presence of imidazole groups as scatterers will complicate the fitting.
There have also been some spectroscopic studies on Cu(II) binding to the neurotoxic fragment PrP-(106 -126) (39, 68) . However, the peptide fragment studied did not have its N terminus acetylated, and is therefore not a good model for this unstructured region of the full-length PrP as Cu 2ϩ will coordinate to the N-terminal amino group at position 106. Cu 2ϩ coordination to the N-terminal amino group of PrP-(106 -126) results in very different spectra from acetylated PrP(H96A) used in this study.
It is clear that copper coordination to PrP is very sensitive to pH. Cu 2ϩ binding and affinity can be modulated by subtle changes in pH. Cu 2ϩ can bind to both the octarepeat region and PrP-(91-115) region at pH values found in the extracellular environment. If the protein is endocytosed via acidified vacuoles, the pH may drop, Cu 2ϩ will be released from the octarepeat region but could still be retained by the PrP-(91-115) region at pH 6. The structuring of PrP-(91-115) upon Cu 2ϩ binding and subsequent pH-dependent restructuring suggests that the region involving residues 91-115 could play a role in signaling endocytosis of PrP. It has been shown that the octarepeat region is essential for copper-mediated endocytosis (7) . Copper binding to the unstructured region outside the octarepeat domain will play a major role in influencing the biological properties of the full-length prion protein. Functionally, this may suggest that the region between the N-terminal octarepeat domain and the structured C-terminal domain acts as a copperdependent "hinge" region. Copper binding to His 96/111 could prepare the octarepeat region for copper binding. Indeed, extending the octarepeat region to incorporate residues between 90 and 115 significantly enhances the affinity and cooperatively of Cu 2ϩ binding to the octarepeats (21, 64) . Studies that show residues 23-90 are not required for prion propagation (30 -32) make the link between disease and Cu 2ϩ binding to the octarepeat region unlikely. However, residues 90 -120 (unstructured in apo-PrP C ) have been shown to be vital for prion propagation (30 -32) . Preferential binding of Cu 2ϩ to this amyloidogenic region of PrP requires us to re-evaluate the role of copper in prion misfolding and disease. The presence of a high affinity Cu 2ϩ site will have profound implications on the copper-loaded structure in this region of PrP C , and can account for the protease resistance of cellular PrP-(90 -231) in vivo (36) . Intriguingly, Cu 2ϩ -dependent protease profiles correspond to similar profiles seen in different strains of prion disease (37) . For the first time we have shown that coordination of a single Cu 2ϩ ion to both His 96 and His 111 has a profound influence on the structuring of this amyloidogenic region inducing a ␤-sheet like conformation. It is this region of PrP that is thought to be key to prion misfolding and disease, and our data suggests a possible role for Cu 2ϩ in triggering this misfolding and amyloidogenesis.
